A proteomic study of resistance to deoxycholate-induced apoptosis

Harris Bernstein, Claire M. Payne, Kathleen Kunke, Cara L. Crowley-Weber, Caroline N. Waltmire, Katerina Dvorakova, Hana Holubec, Carol Bernstein, Richard Vaillancourt, Deborah A. Raynes, Vincent Guerriero, Harinder Garewal

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The development of apoptosis resistance appears to be an important factor in colon carcinogenesis. To gain an understanding of the molecular pathways altered during the development of apoptosis resistance, we selected three cell lines for resistance to induction of apoptosis by deoxycholate, an important etiologic agent in colon cancer. We then evaluated gene expression levels for 825 proteins in these resistant lines, compared with a parallel control line not subject to selection. Eighty-two proteins were identified as either over-expressed or under-expressed in at least two of the resistant lines, compared with the control. Thirty-five of the 82 proteins (43%) proved to have a known role in apoptosis. Of these 35 proteins, 21 were over-expressed and 14 were under-expressed. Of those that were over-expressed 18 of 21 (86%) are anti-apoptotic in some circumstances, of those that were under-expressed 11 of 14 (79%) are pro-apoptotic in some circumstances. This finding suggests that apoptosis resistance during selection among cultured cells, and possibly in the colon during progression to cancer, may arise by constitutive over-expression of multiple anti-apoptotic proteins and under-expression of multiple pro-apoptotic proteins. The major functional groups in which altered expression levels were found are post-translational modification (19 proteins), cell structure (cytoskeleton, microtubule, actin, etc.) (17 proteins), regulatory processes (11 proteins) and DNA repair and cell cycle checkpoint mechanisms (10 proteins). Our findings, overall, bear on mechanisms by which apoptosis resistance arises during progression to colon cancer and suggest potential targets for cancer treatment. In addition, assays of normal-appearing mucosa of colon cancer patients, for over- or under-expression of genes found to be altered in our resistant cell lines, may allow identification of early biomarkers of colon cancer risk.

Original languageEnglish (US)
Pages (from-to)681-692
Number of pages12
JournalCarcinogenesis
Volume25
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Deoxycholic Acid
Proteomics
Apoptosis
Colonic Neoplasms
Proteins
Apoptosis Regulatory Proteins
Colon
Gene Expression
Cell Line
Post Translational Protein Processing
Cell Cycle Checkpoints
Actin Cytoskeleton
Microtubules
DNA Repair
Patient Selection
Cultured Cells
Neoplasms
Carcinogenesis
Mucous Membrane
Biomarkers

ASJC Scopus subject areas

  • Cancer Research

Cite this

Bernstein, H., Payne, C. M., Kunke, K., Crowley-Weber, C. L., Waltmire, C. N., Dvorakova, K., ... Garewal, H. (2004). A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis, 25(5), 681-692. https://doi.org/10.1093/carcin/bgh072

A proteomic study of resistance to deoxycholate-induced apoptosis. / Bernstein, Harris; Payne, Claire M.; Kunke, Kathleen; Crowley-Weber, Cara L.; Waltmire, Caroline N.; Dvorakova, Katerina; Holubec, Hana; Bernstein, Carol; Vaillancourt, Richard; Raynes, Deborah A.; Guerriero, Vincent; Garewal, Harinder.

In: Carcinogenesis, Vol. 25, No. 5, 05.2004, p. 681-692.

Research output: Contribution to journalArticle

Bernstein, H, Payne, CM, Kunke, K, Crowley-Weber, CL, Waltmire, CN, Dvorakova, K, Holubec, H, Bernstein, C, Vaillancourt, R, Raynes, DA, Guerriero, V & Garewal, H 2004, 'A proteomic study of resistance to deoxycholate-induced apoptosis', Carcinogenesis, vol. 25, no. 5, pp. 681-692. https://doi.org/10.1093/carcin/bgh072
Bernstein H, Payne CM, Kunke K, Crowley-Weber CL, Waltmire CN, Dvorakova K et al. A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis. 2004 May;25(5):681-692. https://doi.org/10.1093/carcin/bgh072
Bernstein, Harris ; Payne, Claire M. ; Kunke, Kathleen ; Crowley-Weber, Cara L. ; Waltmire, Caroline N. ; Dvorakova, Katerina ; Holubec, Hana ; Bernstein, Carol ; Vaillancourt, Richard ; Raynes, Deborah A. ; Guerriero, Vincent ; Garewal, Harinder. / A proteomic study of resistance to deoxycholate-induced apoptosis. In: Carcinogenesis. 2004 ; Vol. 25, No. 5. pp. 681-692.
@article{e9e2be90979f420bae62dfc7537cf292,
title = "A proteomic study of resistance to deoxycholate-induced apoptosis",
abstract = "The development of apoptosis resistance appears to be an important factor in colon carcinogenesis. To gain an understanding of the molecular pathways altered during the development of apoptosis resistance, we selected three cell lines for resistance to induction of apoptosis by deoxycholate, an important etiologic agent in colon cancer. We then evaluated gene expression levels for 825 proteins in these resistant lines, compared with a parallel control line not subject to selection. Eighty-two proteins were identified as either over-expressed or under-expressed in at least two of the resistant lines, compared with the control. Thirty-five of the 82 proteins (43{\%}) proved to have a known role in apoptosis. Of these 35 proteins, 21 were over-expressed and 14 were under-expressed. Of those that were over-expressed 18 of 21 (86{\%}) are anti-apoptotic in some circumstances, of those that were under-expressed 11 of 14 (79{\%}) are pro-apoptotic in some circumstances. This finding suggests that apoptosis resistance during selection among cultured cells, and possibly in the colon during progression to cancer, may arise by constitutive over-expression of multiple anti-apoptotic proteins and under-expression of multiple pro-apoptotic proteins. The major functional groups in which altered expression levels were found are post-translational modification (19 proteins), cell structure (cytoskeleton, microtubule, actin, etc.) (17 proteins), regulatory processes (11 proteins) and DNA repair and cell cycle checkpoint mechanisms (10 proteins). Our findings, overall, bear on mechanisms by which apoptosis resistance arises during progression to colon cancer and suggest potential targets for cancer treatment. In addition, assays of normal-appearing mucosa of colon cancer patients, for over- or under-expression of genes found to be altered in our resistant cell lines, may allow identification of early biomarkers of colon cancer risk.",
author = "Harris Bernstein and Payne, {Claire M.} and Kathleen Kunke and Crowley-Weber, {Cara L.} and Waltmire, {Caroline N.} and Katerina Dvorakova and Hana Holubec and Carol Bernstein and Richard Vaillancourt and Raynes, {Deborah A.} and Vincent Guerriero and Harinder Garewal",
year = "2004",
month = "5",
doi = "10.1093/carcin/bgh072",
language = "English (US)",
volume = "25",
pages = "681--692",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - A proteomic study of resistance to deoxycholate-induced apoptosis

AU - Bernstein, Harris

AU - Payne, Claire M.

AU - Kunke, Kathleen

AU - Crowley-Weber, Cara L.

AU - Waltmire, Caroline N.

AU - Dvorakova, Katerina

AU - Holubec, Hana

AU - Bernstein, Carol

AU - Vaillancourt, Richard

AU - Raynes, Deborah A.

AU - Guerriero, Vincent

AU - Garewal, Harinder

PY - 2004/5

Y1 - 2004/5

N2 - The development of apoptosis resistance appears to be an important factor in colon carcinogenesis. To gain an understanding of the molecular pathways altered during the development of apoptosis resistance, we selected three cell lines for resistance to induction of apoptosis by deoxycholate, an important etiologic agent in colon cancer. We then evaluated gene expression levels for 825 proteins in these resistant lines, compared with a parallel control line not subject to selection. Eighty-two proteins were identified as either over-expressed or under-expressed in at least two of the resistant lines, compared with the control. Thirty-five of the 82 proteins (43%) proved to have a known role in apoptosis. Of these 35 proteins, 21 were over-expressed and 14 were under-expressed. Of those that were over-expressed 18 of 21 (86%) are anti-apoptotic in some circumstances, of those that were under-expressed 11 of 14 (79%) are pro-apoptotic in some circumstances. This finding suggests that apoptosis resistance during selection among cultured cells, and possibly in the colon during progression to cancer, may arise by constitutive over-expression of multiple anti-apoptotic proteins and under-expression of multiple pro-apoptotic proteins. The major functional groups in which altered expression levels were found are post-translational modification (19 proteins), cell structure (cytoskeleton, microtubule, actin, etc.) (17 proteins), regulatory processes (11 proteins) and DNA repair and cell cycle checkpoint mechanisms (10 proteins). Our findings, overall, bear on mechanisms by which apoptosis resistance arises during progression to colon cancer and suggest potential targets for cancer treatment. In addition, assays of normal-appearing mucosa of colon cancer patients, for over- or under-expression of genes found to be altered in our resistant cell lines, may allow identification of early biomarkers of colon cancer risk.

AB - The development of apoptosis resistance appears to be an important factor in colon carcinogenesis. To gain an understanding of the molecular pathways altered during the development of apoptosis resistance, we selected three cell lines for resistance to induction of apoptosis by deoxycholate, an important etiologic agent in colon cancer. We then evaluated gene expression levels for 825 proteins in these resistant lines, compared with a parallel control line not subject to selection. Eighty-two proteins were identified as either over-expressed or under-expressed in at least two of the resistant lines, compared with the control. Thirty-five of the 82 proteins (43%) proved to have a known role in apoptosis. Of these 35 proteins, 21 were over-expressed and 14 were under-expressed. Of those that were over-expressed 18 of 21 (86%) are anti-apoptotic in some circumstances, of those that were under-expressed 11 of 14 (79%) are pro-apoptotic in some circumstances. This finding suggests that apoptosis resistance during selection among cultured cells, and possibly in the colon during progression to cancer, may arise by constitutive over-expression of multiple anti-apoptotic proteins and under-expression of multiple pro-apoptotic proteins. The major functional groups in which altered expression levels were found are post-translational modification (19 proteins), cell structure (cytoskeleton, microtubule, actin, etc.) (17 proteins), regulatory processes (11 proteins) and DNA repair and cell cycle checkpoint mechanisms (10 proteins). Our findings, overall, bear on mechanisms by which apoptosis resistance arises during progression to colon cancer and suggest potential targets for cancer treatment. In addition, assays of normal-appearing mucosa of colon cancer patients, for over- or under-expression of genes found to be altered in our resistant cell lines, may allow identification of early biomarkers of colon cancer risk.

UR - http://www.scopus.com/inward/record.url?scp=2442596075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442596075&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgh072

DO - 10.1093/carcin/bgh072

M3 - Article

VL - 25

SP - 681

EP - 692

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 5

ER -